3-(4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-2-yl)-1-(4-morpholinyl)-1-propanone,
apafant,
triazolodiazepine,
WEB 2086,
WEB-2086,
WEB2086,
Apafant,
105219-56-5,
WEB-2086,
Web 2086,
Apafant [USAN:INN],
Apafantum [INN-Latin],
Apafanto [INN-Spanish],
WEB 2086BS,
WEB2086,
UNII-J613NI05SV,
WEB 2086 BS,
BRN 4302553,
C22H22ClN5O2S,
CHEMBL280164,
J613NI05SV,
NCGC00092377-02,
NCGC00092377-03,
Apafanto,
Apafantum,
DSSTox_CID_28900,
DSSTox_RID_83168,
DSSTox_GSID_48974,
4-(3-(4-(o-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepin-2-yl)propionyl)morpholine,
[3H]apafant,
1-Propanone, 3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)-;1-Propanone, 3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)-,
Morpholine, 4-((4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-1-oxopropyl)-,
CAS-105219-56-5,
3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-4-yl]-1-(morpholin-4-yl)propan-1-one,
[3H]WEB 2086,
DE-081,
AC1Q3P7E,
Apafant (JAN/USAN/INN),
Oprea1_587188,
SCHEMBL94167,
3-(4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-2-yl)-1-(4-morpholinyl)-1-propanone,
AC1L246K,
GTPL1859,
GTPL1860,
DTXSID5048974,
CHEBI:92490,
CTK8F0015,
HMS3268N16,
HMS3677G14,
ZINC608180,
Tox21_113429,
Tox21_113594,
BDBM50000714,
PDSP1_000669,
PDSP2_000659,
AKOS024457059,
Tox21_113594_1,
NCGC00092377-01,
NCGC00092377-04,
NCGC00183135-01,
AN-34008,
LS-92643,
ZB014596,
HY-108634,
RT-016257,
WEB2086, >=98% (HPLC),
B7024,
FT-0662248,
D01652,
219W565,
C-33070,
L001111,
SR-01000945084,
J-001361,
SR-01000945084-1,
BRD-K28115081-001-01-9,
(E)-3-(4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl)-1-morpholinopropan-1-one,
3-(4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl)-1-morpholinopropan-1-one,
3-[4-(2-Chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulen-2-yl]-1-morpholin-4-yl-propan-1-one,
3-[4-(2-Chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulen-2-yl]-1-morpholin-4-yl-propan-1-one(WEB 2086),
3-[4-(2-Chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulen-2-yl]-1-morpholin-4-yl-propan-1-one(WEB2086),
4-[3-[4-(2-CHLOROPHENYL)-9-METHYL-6H-THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPIN-2-YL]-1-OXOPROPYL]-MORPHOLINE,
4-[3-[4[(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]diazepin-2-yl]-1-oxopropyl]]morpholine,
4-[3-[4[(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]diazepin-2-yl]-1-oxopropyl]morpholine,
triazolodiazepine,
Apafant [INN],
D07DKC,
D0CB8W,
D0X7ZW,
CID65889,
C22-H22-Cl-N5-O2-S,
Apafant (ophthalmic formulation), Santen,
C052518,
4-[3-[4-(2-chlorophenyl)-9-methyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-oxopropyl]morpholine,
3-[4-(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)-1-propanone,